Vision and Strategy
It is NBE Therapeutics vision to become a leader in antibody-based drug development by developing its own portfolio of drugs until demonstration of a clinical proof-of-concept in man.
- San Diego, USA, 2019-03-04 - NBE-Therapeutics invited to present at Terrapinn's Americas Antibody Congress
- San Diego, USA, 2018-12-11 - NBE-Therapeutics was invited to present at KNect365's 2018 Antibody Engineering & Therapeutics Conference
- Basel, 2018-11-15 - Dr. Anthony Tolcher joins the Scientific Advisory Board of NBE-Therapeutics